Fieller's method and net health benefits

Research output: Contribution to journalArticle

55 Scopus citations

Abstract

Statistical and conceptual difficulties complicate the estimation of the incremental cost-effectiveness ratio (ICER). An alternative approach is to measure cost-effectiveness by the incremental net health benefit (INHB), defined as the difference in mean effectiveness of a new treatment compared with a standard, adjusted for cost difference by subtracting the health foregone if purchasing care at the rate of a marginally cost-effective therapy. Because net health benefit (NHB) is dependent on this threshold rate, one can construct confidence intervals for the INHB at various values of the rate. It turns out that the set of rates where new and standard are not significantly different is equal to the Fieller's method confidence set for the ICER. We review the derivation of the Fieller's method confidence set, present numerical examples, and discuss the implications of our result for the calculation and interpretation of NHB analyses. Copyright (C) 2000 John Wiley and Sons, Ltd.

Original languageEnglish (US)
Pages (from-to)327-335
Number of pages9
JournalHealth Economics
Volume9
Issue number4
DOIs
StatePublished - Jun 1 2000

Keywords

  • Clinical trials
  • Confidence intervals
  • Cost-effectiveness ratios
  • Health economics
  • Pivotal statistic

ASJC Scopus subject areas

  • Health Policy

Fingerprint Dive into the research topics of 'Fieller's method and net health benefits'. Together they form a unique fingerprint.

  • Cite this